2025 Health Care Outlook: Michael Hogue, APhA
By Michael Hogue, CEO, American Pharmacists Association
By Michael Hogue, CEO, American Pharmacists Association
By Ronald Piervincenzi, CEO, U.S. Pharmacopeia
By Lee Ann Stember, President, CEO National Council for Prescription Drug Programs
By Chester ‘Chip’ Davis, President and CEO Healthcare Distribution Alliance (HDA).
By B. Douglas Hoey, CEO, National Community Pharmacists Association
By Steve Anderson, President, CEO National Association of Chain Drug Stores
It’s fair to say that the chain drug industry is at a turning point.
In her keynote address, Rina Shah, senior vice president of pharmacy growth at Walgreens, described how health equity emerged as a central consideration in the drug chain’s strategic planning process and what that means going forward
Reimbursements have declined to a point at which pharmacies lose money when they fill some scripts.
“The U.S. is failing one of its principal obligations as a nation: to protect the health and welfare of its people,” says Dr. Joseph Betancourt, president of the Commonwealth Fund.